Patent ID: 6071693
Filing Date: 2000-06-06
Classification: A61K,C07K,C12N,C12Q

Abstract:
A method of forming a hybridization product with a hepatitis C virus nucleic acid comprising the steps of:(a) placing an isolated or synthesized nucleic acid into conditions in which hybridizations conditions can be imposed, said isolated or synthesized nucleic acid comprising a nucleotide sequence of eight or more contiguous nucleotides fully homologous to or fully complementary to a sequence within a non-HCV-1, hepatitis C viral genome, wherein said sequence is selected from the group consisting of SEQ ID NOs 7-12, 14-17, 19-22, 25-32, 35-36, 38-51, and 53-66, and wherein said isolated or synthesized nucleic acid is capable of forming a hybridization product with said hepatitis C virus nucleic acid, if present under hybridization conditions; and(b) imposing hybridization conditions to form a hybridization product in the presence of hepatitis C virus nucleic acid.